biotin has been researched along with Lymphoma, B-Cell in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, K; Balhorn, MC; Balhorn, R; Rebhun, RB | 1 |
| Li, M; Liu, L; Wang, Y; Xi, N; Xiao, X | 1 |
| Buchegger, F; Chyan, MK; Hamlin, DK; Lin, Y; Pagel, JM; Pantelias, A; Park, SI; Press, OW; Shenoi, J; Wan, F; Wilbur, DS; Wilbur, SM | 1 |
| Axworthy, D; Hedin, N; Mallet, R; Matthews, DC; Meyer, D; Pagel, JM; Press, OW; Subbiah, K; Theodore, LJ; Wilbur, DS | 1 |
| Dreisbach, SK; Gercel-Taylor, C; Metzinger, DS; Shirwan, H; Singh, NP; Taylor, DD; Yolcu, ES | 1 |
| Cavallin-Ståhl, E; Garkavij, M; Kurkus, J; Lindén, O; Ljungberg, M; Nilsson, R; Ohlsson, T; Sandberg, B; Strand, SE; Tennvall, J | 1 |
| Axworthy, D; Hedin, N; Lin, Y; Pagel, JM; Pantelias, A; Press, OW | 1 |
| Cook, DR; Curiel, DT; Curiel, TJ; Glode, LM; Maxwell, F; Maxwell, IH; Purner, MB; Stevens, JO; Wagner, E | 1 |
| Chen, R; Luo, JH; Matsushima, AY; Szabolcs, MJ | 1 |
| Kovár, M; Ríhová, B; Strohalm, J; Ulbrich, K | 1 |
1 trial(s) available for biotin and Lymphoma, B-Cell
| Article | Year |
|---|---|
A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
Topics: Adsorption; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biotin; Biotinylation; Cell Line, Tumor; Clinical Trials as Topic; Hemadsorption; Humans; Immunoconjugates; Indium Radioisotopes; Kidney; Liver; Lymphoma, B-Cell; Radioimmunodetection; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rituximab; Time Factors; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2005 |
9 other study(ies) available for biotin and Lymphoma, B-Cell
| Article | Year |
|---|---|
The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancers.
Topics: Antibodies; Antineoplastic Agents; Biotin; Cell Line, Tumor; HLA-DR Serological Subtypes; Humans; Leukocytes, Mononuclear; Ligands; Lymphoma, B-Cell; Molecular Docking Simulation; Piperazines; Pyridines | 2020 |
Rapid recognition and functional analysis of membrane proteins on human cancer cells using atomic force microscopy.
Topics: Antigens, CD20; Avidin; Biomarkers; Biotin; Cell Line; Cell Membrane; Humans; Lymphoma, B-Cell; Membrane Proteins; Microscopy, Atomic Force; Reproducibility of Results; Rituximab | 2016 |
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
Topics: Acetylgalactosamine; Animals; Antigens, CD20; Biotin; Cell Line, Tumor; Chelating Agents; Drug Design; Heterocyclic Compounds, 1-Ring; Humans; Lymphoma, B-Cell; Mice; Molecular Structure; Mutation; Recombinant Fusion Proteins; Single-Chain Antibodies; Streptavidin; Xenograft Model Antitumor Assays | 2010 |
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Biotin; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Leukocyte Common Antigens; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organometallic Compounds; Radioimmunotherapy; Remission Induction; Streptavidin; Tumor Cells, Cultured; Yttrium Radioisotopes | 2003 |
A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.
Topics: Animals; Antigen-Presenting Cells; B7-1 Antigen; Biotin; Female; Gene Transfer Techniques; Genital Neoplasms, Female; Humans; Immunotherapy, Adoptive; Lymphocyte Activation; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Rabbits; Recombinant Fusion Proteins; Streptavidin; T-Lymphocytes; Tumor Cells, Cultured | 2003 |
A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
Topics: Amino Acid Sequence; Animals; Base Sequence; Biotin; Cell Line, Tumor; Female; Humans; Immunoglobulin Fragments; Leukocyte Common Antigens; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Organometallic Compounds; Protein Engineering; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Streptavidin; Ytterbium | 2006 |
Gene therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria toxin gene delivered by a novel adenovirus-polylysine conjugate.
Topics: Adenoviridae; Animals; Biotin; Cell Line, Transformed; Diphtheria Toxin; DNA, Recombinant; Female; Gene Expression Regulation, Neoplastic; Genes, Immunoglobulin; Genes, Reporter; Genes, Synthetic; Genetic Therapy; Herpesvirus 4, Human; Immunoglobulin kappa-Chains; Ligands; Lymphoma, B-Cell; Male; Mice; Mice, SCID; Peptide Fragments; Polylysine; Promoter Regions, Genetic; Recombinant Fusion Proteins | 1994 |
Detection of CD5 antigen on B cell lymphomas in fixed, paraffin embedded tissues using signal amplification by catalyzed reporter deposition.
Topics: Biotin; Catalysis; CD5 Antigens; Humans; Lymphoma, B-Cell; Paraffin Embedding; Staining and Labeling; Tissue Fixation; Tyramine | 1998 |
In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Biotin; Cell Division; Doxorubicin; Flow Cytometry; Indicators and Reagents; Ligands; Lymphoma, B-Cell; Methacrylates; Mice; Mice, Inbred C3H; Receptors, Transferrin; Transferrin | 2002 |